{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/OPRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T10:13:21.524Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3639,"canonical_name":"OptimizeRx Corp","cik":"0001448431","uei":null,"lei":null,"duns":null,"ticker":"OPRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":38},"count":38,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-10-02","url_slug":"/sec/cik-0001448431/4/0001628280-26-064386","accession_number":"0001628280-26-064386","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-09-02","url_slug":"/sec/cik-0001448431/4/0001628280-26-060059","accession_number":"0001628280-26-060059","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058583","accession_number":"0001628280-26-058583","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058584","accession_number":"0001628280-26-058584","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058586","accession_number":"0001628280-26-058586","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058588","accession_number":"0001628280-26-058588","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058589","accession_number":"0001628280-26-058589","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058669","accession_number":"0001628280-26-058669","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058670","accession_number":"0001628280-26-058670","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058672","accession_number":"0001628280-26-058672","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-08-24","url_slug":"/sec/cik-0001448431/4/0001628280-26-058673","accession_number":"0001628280-26-058673","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"S-8","title":"S-8 — OptimizeRx Corp — 2026-08-20","url_slug":"/sec/cik-0001448431/s-8/0001213900-26-092097","accession_number":"0001213900-26-092097","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — OptimizeRx Corp — 2026-08-14","url_slug":"/sec/cik-0001448431/schedule-13g/0000884589-26-000012","accession_number":"0000884589-26-000012","importance":55},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — OptimizeRx Corp — 2026-08-13","url_slug":"/sec/cik-0001448431/10-q/0001448431-26-000016","accession_number":"0001448431-26-000016","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — OptimizeRx Corp — 2026-08-12","url_slug":"/sec/cik-0001448431/8-k/0001448431-26-000014","accession_number":"0001448431-26-000014","importance":35},{"ts":"2026-07-29","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — OptimizeRx Corp — 2026-07-29","url_slug":"/sec/cik-0001448431/schedule-13g-a/0002012383-26-002843","accession_number":"0002012383-26-002843","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — OptimizeRx Corp — 2026-07-22","url_slug":"/sec/cik-0001448431/schedule-13g/0000906304-26-000124","accession_number":"0000906304-26-000124","importance":55},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — OptimizeRx Corp — 2026-06-12","url_slug":"/sec/cik-0001448431/8-k/0001213900-26-068272","accession_number":"0001213900-26-068272","importance":35},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-06-10","url_slug":"/sec/cik-0001448431/4/0001628280-26-042124","accession_number":"0001628280-26-042124","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-06-10","url_slug":"/sec/cik-0001448431/4/0001628280-26-042129","accession_number":"0001628280-26-042129","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-06-10","url_slug":"/sec/cik-0001448431/4/0001628280-26-042131","accession_number":"0001628280-26-042131","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-06-10","url_slug":"/sec/cik-0001448431/4/0001628280-26-042132","accession_number":"0001628280-26-042132","importance":30},{"ts":"2026-06-09","kind":"sec.insider.a","reporter":"WASSON GREGORY D","title":"","shares":34517,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-09","kind":"sec.insider.a","reporter":"KLEMA CATHY","title":null,"shares":34517,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-09","kind":"sec.insider.a","reporter":"Spangler Patrick D","title":"","shares":34517,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-09","kind":"sec.insider.a","reporter":"Vos Ellen O'Connor","title":"","shares":34517,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-09","kind":"sec.insider.a","reporter":"Presti Mariyamma Varghese","title":null,"shares":17258,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-09","kind":"sec.insider.a","reporter":"Lang James Paul","title":"","shares":34517,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.filing","form_type":"8-K","title":"8-K — OptimizeRx Corp — 2026-06-05","url_slug":"/sec/cik-0001448431/8-k/0001213900-26-065810","accession_number":"0001213900-26-065810","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — OptimizeRx Corp — 2026-06-01","url_slug":"/sec/cik-0001448431/defa14a/0001213900-26-063148","accession_number":"0001213900-26-063148","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-05-18","url_slug":"/sec/cik-0001448431/4/0001628280-26-035998","accession_number":"0001628280-26-035998","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — OptimizeRx Corp — 2026-05-18","url_slug":"/sec/cik-0001448431/4/0001628280-26-036004","accession_number":"0001628280-26-036004","importance":30},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Silvestro Stephen L","title":"Chief Executive Officer","shares":5219,"price_per_share":5.21,"usd_value":27191,"security_title":"Common Stock","importance":15.02719099},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Greco Theresa","title":"Chief Commercial Officer","shares":914,"price_per_share":5.21,"usd_value":4762,"security_title":"Common Stock","importance":15.00476194},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Greco Theresa","title":"Chief Commercial Officer","shares":879,"price_per_share":5.21,"usd_value":4580,"security_title":"Common Stock","importance":15.00457959},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — OptimizeRx Corp — 2026-05-13","url_slug":"/sec/cik-0001448431/10-q/0001448431-26-000011","accession_number":"0001448431-26-000011","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — OptimizeRx Corp — 2026-05-12","url_slug":"/sec/cik-0001448431/8-k/0001448431-26-000009","accession_number":"0001448431-26-000009","importance":35},{"ts":"2026-05-01","kind":"sec.insider.a","reporter":"Presti Mariyamma Varghese","title":null,"shares":13060,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15}]}